A detailed history of Tevis Investment Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tevis Investment Management holds 26,582 shares of MRK stock, worth $2.64 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares
26,582
Previous 26,400 0.69%
Holding current value
$2.64 Million
Previous $3.27 Million 7.65%
% of portfolio
2.25%
Previous 2.65%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$111.15 - $128.97 $20,229 - $23,472
182 Added 0.69%
26,582 $3.02 Million
Q2 2024

Jul 23, 2024

BUY
$123.8 - $132.96 $866 - $930
7 Added 0.03%
26,400 $3.27 Million
Q1 2024

Apr 16, 2024

SELL
$113.24 - $131.95 $54,015 - $62,940
-477 Reduced 1.78%
26,393 $3.48 Million
Q4 2023

Jan 19, 2024

BUY
$100.18 - $109.02 $94,670 - $103,023
945 Added 3.65%
26,870 $2.93 Million
Q3 2023

Oct 16, 2023

SELL
$102.95 - $114.33 $32,429 - $36,013
-315 Reduced 1.2%
25,925 $2.67 Million
Q2 2023

Aug 01, 2023

SELL
$108.61 - $118.38 $49,526 - $53,981
-456 Reduced 1.71%
26,240 $3.03 Million
Q1 2023

May 02, 2023

BUY
$102.94 - $114.86 $12,558 - $14,012
122 Added 0.46%
26,696 $2.84 Million
Q4 2022

Jan 30, 2023

SELL
$87.44 - $112.11 $9,093 - $11,659
-104 Reduced 0.39%
26,574 $2.95 Million
Q3 2022

Nov 07, 2022

BUY
$84.53 - $94.96 $26,204 - $29,437
310 Added 1.18%
26,678 $2.3 Million
Q2 2022

Aug 08, 2022

BUY
$83.49 - $94.64 $76,727 - $86,974
919 Added 3.61%
26,368 $2.41 Million
Q1 2022

Aug 05, 2022

BUY
$73.51 - $82.4 $1.33 Million - $1.49 Million
18,099 Added 246.24%
25,449 $2.09 Million
Q4 2021

Aug 05, 2022

BUY
$72.28 - $90.54 $531,258 - $665,469
7,350 New
7,350 $563,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Tevis Investment Management Portfolio

Follow Tevis Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tevis Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Tevis Investment Management with notifications on news.